<DOC>
	<DOCNO>NCT03011281</DOCNO>
	<brief_summary>The objective single center , prospective , non-interventional inception cohort understand patient characteristic , general treatment pattern , effectiveness , safety Tofacitinib rheumatoid arthritis patient real-world setting . 1 . To evaluate baseline characteristic Korean RA patient treat Tofacitinib 2 . To evaluate effectiveness safety Tofacitinib clinical practice Korean RA patient . 3 . To evaluate safety , effectiveness demographic characteristic patient treat Tofacitinib match compare biologic DMARDs BIOPSY registry database .</brief_summary>
	<brief_title>Effectiveness Safety Tofacitinib Korean Patients With Rheumatoid Arthritis</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Tofacitinib</mesh_term>
	<criteria>A . Patients provide write informed consent form participate study . B . Patients 19 year old . C. Patients moderately severely active rheumatoid arthritis define per EULAR guideline , inadequate response intolerant methotrexate . A . Patients provide write informed consent form participate study</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>